Cite
HARVARD Citation
Shepherd, J. et al. (2022). CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer. Journal of clinical oncology. 40 (12), pp. 1323-1334. [Online].